Pages that link to "Q36079860"
Jump to navigation
Jump to search
The following pages link to The role of BAFF in immune function and implications for autoimmunity (Q36079860):
Displaying 41 items.
- Atacicept: targeting B cells in multiple sclerosis (Q24628925) (← links)
- The riddle of the dual expression of IgM and IgD (Q24682937) (← links)
- Multiple Roles for B-Lymphocytes in Sjogren's Syndrome (Q28068695) (← links)
- An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity (Q28303311) (← links)
- Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders (Q33385389) (← links)
- Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells (Q33440567) (← links)
- Differences in mouse and human nonmemory B cell pools (Q33716235) (← links)
- The function of BAFF on T helper cells in autoimmunity (Q33748041) (← links)
- Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice (Q34044394) (← links)
- B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation. (Q34159016) (← links)
- A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study (Q34416115) (← links)
- MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts (Q34434727) (← links)
- Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human (Q34503355) (← links)
- B cells move to centre stage: novel opportunities for autoimmune disease treatment (Q34544062) (← links)
- Antigen Is Required for Maturation and Activation of Pathogenic Anti-DNA Antibodies and Systemic Inflammation (Q35334977) (← links)
- Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival (Q36384731) (← links)
- An APRIL to remember: novel TNF ligands as therapeutic targets (Q36394955) (← links)
- Contemporary treatment of systemic lupus erythematosus: an update for clinicians. (Q36443689) (← links)
- Control of canonical NF-kappaB activation through the NIK-IKK complex pathway (Q36491362) (← links)
- The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity (Q36622367) (← links)
- IL5RA and TNFRSF6B gene variants are associated with sporadic IgA nephropathy (Q36662159) (← links)
- B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma (Q36778126) (← links)
- B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation (Q37009908) (← links)
- Manipulating B cell homeostasis: a key component in the advancement of targeted strategies (Q37177128) (← links)
- B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis (Q37690672) (← links)
- Janus head: the dual role of HLA-G in CNS immunity (Q37810517) (← links)
- Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis. (Q37968620) (← links)
- Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis (Q39485889) (← links)
- Pharmacokinetics and pharmacodynamics of anti-BR3 monoclonal antibody in mice (Q39985668) (← links)
- B-cell activating factor BAFF reflects patients' immunological risk profile after kidney transplantation. (Q40059905) (← links)
- Selective regulation of autoreactive B cells by FcgammaRIIB. (Q41970239) (← links)
- B-cell tolerance in transplantation: is repertoire remodeling the answer? (Q42038591) (← links)
- Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells (Q42510282) (← links)
- [Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis]. (Q51890165) (← links)
- [Targeting B cells in multiple sclerosis. Current concepts and strategies]. (Q51958899) (← links)
- BAFF costimulation of Toll-like receptor-activatedB-1 cells (Q58225712) (← links)
- Recent advances in the management of systemic lupus erythematosus (Q64044243) (← links)
- Abnormal high expression of B-cell activating factor belonging to the TNF superfamily (BAFF) associated with long-term outcome in kidney transplant recipients (Q84104588) (← links)
- [New therapeutic targets] (Q84600763) (← links)
- Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection (Q90479619) (← links)
- Immunological Characteristics in Refractory Chronic Rhinosinusitis with Nasal Polyps Undergoing Revision Surgeries (Q92101160) (← links)